|

EDS01 5.0×10^11 VP + Toripalimab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • West China Hospital1

Indications

  • Head Neck Cancer1
  • Nasopharyngeal Cancinoma (NPC)1
  • Cancer1

Other1 trial

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.